Who Paid My Doc
Farapulse
Device Structural Heart
General payments
$237,118
Research payments
$6,541,013
Through program year 2025, $237,118 in general payments and $6,541,013 in research payments were reported against Farapulse (Structural Heart).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,500 | 1 |
| 2024 | General | $400 | 1 |
| 2023 | General | $23,015 | 14 |
| 2023 | Research | $1,037,281 | 232 |
| 2022 | General | $84,220 | 22 |
| 2022 | Research | $3,570,658 | 473 |
| 2021 | General | $129,483 | 18 |
| 2021 | Research | $1,931,574 | 107 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
55 general · 813 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.